The study presented in this article used a controlled-porosity osmotic pump, which was prepared in the form of a bilayered tablet containing a drug compartment and an osmogen layer for the delayed release of diltiazem HCI.
Kilambi Pundarikakshudu, PhD
Advertisement
Kilambi Pundarikakshudu, PhD, is a professor at Shree S.K. Patel College of Pharmaceutical Education and Research, "Ganpat Vidyanagar."
Articles by Kilambi Pundarikakshudu, PhD
Advertisement
Latest Updated Articles
- The Fabrication And Evaluation of the Formulation Variables of a Controlled-Porosity Osmotic Drug Delivery System with Diltiazem Hydrochloride
Published: September 2nd 2003 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
The Key Trends Driving Supply Chain Localization and Data Scrutiny in Biopharma
2
CPHI 2025 Awards Spotlight Breakthroughs in Pharmaceutical Manufacturing and API Development
3
Clearing Hurdles in Sustainability, AI, and CDMO Partnerships
4
Excipient Innovation, Safer Solvents, and Supply Chain Resilience
5
